NASDAQ:VTL Vital Therapies (VTL) Stock Price, News & Analysis → The biggest energy story ever? (From Porter & Company) (Ad) Free VTL Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$1.26▼$1.3450-Day Range$0.83▼$14.5052-Week Range$0.15▼$9.75Volume127,187 shsAverage Volume21.62 million shsMarket Capitalization$55.08 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisCompetitorsHeadlinesSocial MediaStock AnalysisCompetitorsHeadlinesSocial Media Get Vital Therapies alerts: Email Address Ad Paradigm PressBiden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report About Vital Therapies Stock (NASDAQ:VTL)Immunic, Inc. develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. Its products include IMU-838, IMU-935, and IMU-856. The company is headquartered in San Diego, CA.Read More Ad Paradigm PressBiden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report VTL Stock News HeadlinesApril 28, 2024 | yahoo.comVital Spa celebrates a year on Bridge StreetMarch 8, 2024 | yahoo.comWhat is therapeutic recreation? Champaign counselors train to include it in their sessionsMay 2, 2024 | Weiss Ratings (Ad)Protect Your Bank Account Before It’s Too LateFor months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction …March 2, 2024 | morningstar.comVital Ltd VTLMarch 2, 2024 | msn.comThe Benefits of Teen Outpatient Programs for Behavioral HealthMarch 1, 2024 | wsj.comVital Ltd.February 29, 2024 | news.yahoo.com‘Vital’ new treatment center for high-risk kids seeks $8 million in funding from Oregon lawmakersFebruary 13, 2024 | msn.comNorth Carolina tells nature-based therapy program to stop admissions during probe of boy’s deathMay 2, 2024 | Weiss Ratings (Ad)Protect Your Bank Account Before It’s Too LateFor months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction …December 7, 2023 | msn.com5 for Good: Therapeutic riding program helps build strength, social skillsSeptember 7, 2023 | msn.comWorld Physical Therapy Day 2023: Date, history, theme, significance and all you need to knowAugust 8, 2023 | forbes.comBest Online Therapy For Anxiety Of 2023July 21, 2023 | forbes.comVital Proteins Collagen Peptides Review 2023July 12, 2023 | msn.comESPN’s Dick Vitale diagnosed with cancer for a third timeJuly 3, 2023 | msn.comVitiligo through Ayurveda lens: Diet and lifestyle tips for holistic treatmentJune 27, 2023 | washingtonpost.comMultiple myeloma has long been a killer. Therapies are changing that.May 26, 2023 | health.usnews.comHow to Prepare for Your First Physical Therapy SessionMay 25, 2023 | forbes.comTalk Therapy: What It Is, Types And EffectivenessMay 5, 2023 | sfgate.com10 Best Online Therapy Services for Virtual Counseling in 2023May 4, 2023 | forbes.comYour Guide To Cognitive Behavioral Therapy (CBT)April 15, 2023 | forbes.com5 Best Online Therapy For Teens Of 2023March 23, 2023 | money.usnews.comOccupational Therapy AssistantMarch 14, 2023 | seekingalpha.comNew weight loss therapies can burden Medicare - expertsFebruary 26, 2023 | benzinga.comTaysha Gene Therapies Stock (NASDAQ:TSHA), Quotes and News SummaryJanuary 12, 2023 | finance.yahoo.comAsthma & COPD Therapies Market Report 2023-2033November 30, 2022 | benzinga.comMomentum at South Bay for Rehabilitation and Nursing Earns Industry Quality AwardNovember 11, 2022 | nz.finance.yahoo.comVital Limited (VTL.NZ)See More Headlines Receive VTL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vital Therapies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/07/2018Today5/01/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:VTL CUSIPN/A CIK1280776 Webvitaltherapies.com Phone(858) 673-6840FaxN/AEmployees10Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-41,470,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-235.33% Return on Assets-182.35% Debt Debt-to-Equity RatioN/A Current Ratio6.97 Quick Ratio6.97 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.29 per share Price / Book4.48Miscellaneous Outstanding Shares42,370,000Free FloatN/AMarket Cap$55.08 million OptionableNot Optionable Beta3.51 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesDaniel VittPresident, Chief Executive Officer & DirectorManfred GröppelChief Operating OfficerGlenn WhaleyVP-Finance, Chief Financial & Accounting OfficerAndreas MuehlerChief Medical OfficerHella KohlhofChief Scientific OfficerKey CompetitorsBioLineRxNASDAQ:BLRXEagle PharmaceuticalsNASDAQ:EGRXHCW BiologicsNASDAQ:HCWBEquilliumNASDAQ:EQLantern PharmaNASDAQ:LTRNView All Competitors VTL Stock Analysis - Frequently Asked Questions How were Vital Therapies' earnings last quarter? Vital Therapies, Inc. (NASDAQ:VTL) issued its quarterly earnings results on Tuesday, August, 7th. The company reported ($0.30) EPS for the quarter, beating analysts' consensus estimates of ($0.33) by $0.03. What other stocks do shareholders of Vital Therapies own? Based on aggregate information from My MarketBeat watchlists, some companies that other Vital Therapies investors own include Xtrackers California Municipal Bond ETF (CA), BlackRock (BLK), Endologix (ELGX), Anthera Pharmaceuticals (ANTH), Novavax (NVAX), Viking Therapeutics (VKTX), ACADIA Pharmaceuticals (ACAD), Allergan (AGN), Aegean Marine Petroleum Network (ANW) and Chipotle Mexican Grill (CMG). This page (NASDAQ:VTL) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics😱 This phenomenon is smashing regular market gainsMillPubDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingForget Nvidia. This is the future of AIPorter & CompanyAI “wealth window” is closing June 25thParadigm Press4 coins to be the “Next Bitcoin”True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vital Therapies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
